Skip to Content


In the US, Ibutilide (ibutilide systemic) is a member of the drug class group III antiarrhythmics and is used to treat Atrial Fibrillation and Atrial Flutter.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Antiarrhythmic agent, class III

Chemical Name

Metanesulfonamide, N-[4-[4-(etylheptylamino)-1-hydroxybutyl]phenyl]-, (±)-

Foreign Names

  • Ibutilidum (Latin)
  • Ibutilid (German)
  • Ibutilide (French)
  • Ibutilida (Spanish)

Generic Names

  • Ibutilide (OS: BAN)
  • Ibutilide Fumarate (OS: BANM, USAN)
  • Ibutilid hemifumarat (IS)
  • U 70226 E (IS: Upjohn)

Brand Names

  • Corvert
    Alapis Pharma, Greece; Pfizer, Austria; Pfizer, Canada; Pfizer, Switzerland; Pfizer, Finland; Pfizer, Netherlands; Pfizer, Norway; Pfizer, Sweden; Pfizer Italia, Italy; Pharmacia & Upjohn, United States


BANBritish Approved Name
BANMBritish Approved Name (Modified)
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.